IRIS
Inga, Alberto
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 12.990
AS - Asia 3.295
EU - Europa 2.553
SA - Sud America 617
Continente sconosciuto - Info sul continente non disponibili 390
AF - Africa 83
OC - Oceania 15
Totale 19.943
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.744
SG - Singapore 1.394
VN - Vietnam 703
CN - Cina 567
BR - Brasile 494
IT - Italia 459
RU - Federazione Russa 447
SE - Svezia 299
GB - Regno Unito 220
FI - Finlandia 215
UA - Ucraina 194
DE - Germania 187
CA - Canada 159
FR - Francia 153
LV - Lettonia 115
IN - India 93
KR - Corea 89
HK - Hong Kong 85
ID - Indonesia 58
BD - Bangladesh 55
BG - Bulgaria 47
AR - Argentina 41
JP - Giappone 41
JO - Giordania 38
TR - Turchia 37
MX - Messico 34
NL - Olanda 34
IQ - Iraq 32
PL - Polonia 30
LT - Lituania 27
AT - Austria 26
ES - Italia 24
CO - Colombia 23
ZA - Sudafrica 23
EC - Ecuador 20
CZ - Repubblica Ceca 19
CL - Cile 13
IL - Israele 13
JM - Giamaica 13
MA - Marocco 13
PH - Filippine 13
PK - Pakistan 13
GR - Grecia 12
UZ - Uzbekistan 11
VE - Venezuela 11
AU - Australia 10
DZ - Algeria 8
IE - Irlanda 8
SC - Seychelles 8
TT - Trinidad e Tobago 8
CR - Costa Rica 7
KE - Kenya 7
MY - Malesia 7
AL - Albania 6
BE - Belgio 6
NI - Nicaragua 6
NP - Nepal 6
AO - Angola 5
CH - Svizzera 5
NZ - Nuova Zelanda 5
PE - Perù 5
SA - Arabia Saudita 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EG - Egitto 4
ET - Etiopia 4
HN - Honduras 4
KZ - Kazakistan 4
LK - Sri Lanka 4
PY - Paraguay 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CW - ???statistics.table.value.countryCode.CW??? 3
DK - Danimarca 3
OM - Oman 3
TH - Thailandia 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BH - Bahrain 2
BO - Bolivia 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
EU - Europa 2
GA - Gabon 2
GD - Grenada 2
HR - Croazia 2
KG - Kirghizistan 2
LI - Liechtenstein 2
LU - Lussemburgo 2
MQ - Martinica 2
NG - Nigeria 2
NO - Norvegia 2
PT - Portogallo 2
QA - Qatar 2
SR - Suriname 2
UY - Uruguay 2
BF - Burkina Faso 1
BJ - Benin 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
Totale 19.544
Salva come PNG Salva come JPEG
Città #
Ashburn 1.494
Fairfield 1.386
Chandler 916
Singapore 879
San Jose 649
Woodbridge 608
Seattle 604
Houston 520
Wilmington 457
Jacksonville 454
Cambridge 453
Dallas 422
Council Bluffs 333
Santa Clara 306
Columbus 300
Ann Arbor 276
Ho Chi Minh City 178
Moscow 177
Hanoi 172
Princeton 171
New York 170
San Mateo 159
Los Angeles 142
The Dalles 131
Beijing 125
Phoenix 121
Helsinki 119
Riga 115
Lauterbourg 97
Trento 92
Seoul 84
San Diego 78
Boardman 75
Hong Kong 72
Chicago 66
São Paulo 66
Munich 65
London 62
Dong Ket 55
Dearborn 50
Orem 48
Buffalo 47
Montreal 45
San Paolo di Civitate 45
Sofia 44
Da Nang 43
Jakarta 40
Lawrence 39
Milan 39
Fremont 38
North Bergen 38
Atlanta 36
Falls Church 36
Tokyo 33
Washington 33
Rome 30
Toronto 29
Nuremberg 28
Haiphong 27
Warsaw 27
Como 26
Denver 26
Brooklyn 24
Hefei 21
Vilnius 20
Des Moines 18
Redondo Beach 18
Belo Horizonte 17
Bremen 17
Chennai 17
Frankfurt am Main 17
Izmir 17
Brno 16
Norwalk 15
Rio de Janeiro 15
Shanghai 15
Falkenstein 14
Johannesburg 14
Mumbai 14
Stockholm 14
Turku 14
Mountain View 13
Poplar 13
Riva Del Garda 13
Amsterdam 12
Genoa 12
Guangzhou 12
Vienna 12
Baghdad 11
Hải Dương 11
Paris 11
Salt Lake City 11
Brasília 10
Corinth 10
Elk Grove Village 10
Philadelphia 10
Biên Hòa 9
Boston 9
Charlotte 9
Manchester 9
Totale 14.020
Salva come PNG Salva come JPEG
Nome #
A highly specific SpCas9 variant is identified by in vivo screening in yeast 362
Inherited determinants of early recurrent somatic mutations in prostate cancer 354
Conserved Pseudoknots in lncRNA MEG3 Are Essential for Stimulation of the p53 Pathway 346
Human transcription factors in yeast: the fruitful examples of P53 and NF-кB 337
The ribonucleic complex HuR-MALAT1 represses CD133 expression and suppresses epithelial-mesenchymal transition in breast cancer 296
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma 284
Decoding c-Myc networks of cell cycle and apoptosis regulated genes in a transgenic mouse model of papillary lung adenocarcinomas 283
RiboAbacus: a model trained on polyribosome images predicts ribosome density and translational efficiency from mammalian transcriptomes 260
Whole-genome cartography of p53 response elements ranked on transactivation potential 247
Functional analysis of a CDKN2A 5'UTR germline variant associated with pancreatic cancer development 246
A Cross-Platform Comparison of Affymetrix and Agilent Microarrays Reveals Discordant miRNA Expression in Lung Tumors of c-Raf Transgenic Mice 235
Identification of a core TP53 transcriptional program with highly distributed tumor suppressive activity 235
Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells 229
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 225
Quantitative Analysis of NF-κB Transactivation Specificity Using a Yeast-Based Functional Assay 225
c-Myc targeted regulators of cell metabolism in a transgenic mouse model of papillary lung adenocarcinoma. 225
Synthesis of 2,6-diamino-substituted purine derivatives and evaluation of cell cycle arrest in breast and colorectal cancer cells 223
A functional genetic study identifies HAND1 mutations in septation defects of the human heart. 222
Allele-specific genomic data elucidate the role of somatic gain and copy-number neutral loss of heterozygosity in cancer 222
DIMP53-1: a novel small-molecule dual inhibitor of p53-MDM2/X interactions with multifunctional p53-dependent anticancer properties 221
Functional analysis of CDKN2A/p16INK4a 5 ' UTR variants predisposing to melanoma 219
Evolution of p53 transactivation specificity through the lens of a yeast-based functional assay 219
A loss-of-function mutation in the binding domain of HAND1 predicts hypoplasia of the human hearts. 218
LncRNA EPR controls epithelial proliferation by coordinating Cdkn1a transcription and mRNA decay response to TGF-β 214
Yeast as a chassis for developing functional assays to study human P53 211
The 5'-untranslated region of p16INK4a melanoma tumor suppressor acts as a cellular IRES, controlling mRNA translation under hypoxia through YBX1 binding 210
P53 Family Members Modulate the Expression of PRODH, but Not PRODH2, via Intronic p53 Response Elements. 208
Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approach. 206
Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence code. 206
The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis. 203
The CDKN2A/p16(INK) (4a) 5'UTR sequence and translational regulation: impact of novel variants predisposing to melanoma 201
Apigenin rich-Limonium duriusculum (de Girard) Kuntze promotes apoptosis in HCT116 cancer cells 198
Translation control can shape TP53-dependent cell fate 197
Characterization of the p53 mutants ability to inhibit p73β transactivation using a yeast-based functional assay 195
A selective p53 activator and anticancer agent to improve colorectal cancer therapy 194
Changing the p53 master regulatory network: ELEMENTary, my dear Mr Watson. 193
p53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening system 192
A single-nucleotide polymorphism in a half-binding site creates p53 and estrogen receptor control of vascular endothelial growth factor receptor 1. 192
Structure of p73 DNA-binding domain tetramer modulates p73 transactivation. 188
A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network 187
Regulatory Crosstalk of Doxorubicin, Estradiol and TNFα Combined Treatment in Breast Cancer-derived Cell Lines 187
Contribution of yeast and plant research for improving human health. 186
3-Methyl-3-deazaadenine, a stable isostere of N3-methyl-adenine, is efficiently bypassed by replication in vivo and by transcription in vitro. 186
EEC- and ADULT-associated TP63 mutations exhibit functional heterogeneity toward P63 responsive sequences. 184
SMN-primed ribosomes modulate the translation of transcripts related to spinal muscular atrophy 184
Cooperative interactions between p53 and NFκB enhance cell plasticity. 183
Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes. 181
In-silico identification and functional validation of allele-dependent AR enhancers 181
Nutlin-Induced Apoptosis Is Specified by a Translation Program Regulated by PCBP2 and DHX30 180
The coordinated p53 and estrogen receptor cis-regulation at an FLT1 promoter SNP is specific to genotoxic stress and estrogenic compound. 178
JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress. 178
Interaction between p53 and estradiol pathways in transcriptional responses to chemotherapeutics. 178
Mutagenicity of N3-methyladenine: a multi-translesion polymerase affair. 176
p53-directed translational control can shape and expand the universe of p53 target genes. 176
Functional analysis of CDKN2A/p16INK4a 5'-UTR variants predisposing to melanoma 175
MicroRNA-based, p53 dependent post-transcriptional circuits: mechanisms, targets and inter-individual variation 174
Functional analysis of CDKN2A 5'UTR variants associated with family history of melanoma 172
Altered-function p53 missense mutations identified in breast cancers can have subtle effects on transactivation. 172
Comparison of the biological effects of MMS and Me-lex, a minor groove methylating agent: Clarifying the role of N3-methyladenine. 170
Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-molecule 169
Α-mangostin and gambogic acid as potential inhibitors of the p53-MDM2 interaction revealed by a yeast approach. 167
Identification of new p53 target microRNAs by bioinformatics and functional analysis 167
LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis 165
TP53 Mutants in the Tower of Babel of Cancer Progression. 165
The expanding universe of p53 targets 163
High frequency of genomic deletions induced by Me-lex, a sequence selective N3-adenine methylating agent, at the Hprt locus in Chinese hamster ovary cells. 162
Transcriptional properties of feline p53 and its tumour-associated mutants: a yeast-based approach. 161
P63 modulates the expression of the WDFY2 gene which is implicated in cancer regulation and limb development 161
Influences of base excision repair defects on the lethality and mutagenicity induced by Me-lex, a sequence-selective N3-adenine methylating agent 156
DHX30 coordinates cytoplasmic translation and mitochondrial function contributing to cancer cell survival 156
More targets, more pathways and more clues for mutant p53. 153
Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interaction. 151
Studying RNP Composition with RIP 151
Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation 150
Structural studies on mechanisms to activate mutant p53. 148
Transactivation by partial function P53 family mutants is increased by the presence of G-quadruplexes at a promoter site 147
The structure formed by inverted repeats in p53 response elements determines the transactivation activity of p53 protein 147
Transcriptional defect of an inherited NKX2-5 haplotype comprising a SNP, a nonsynonymous and a synonymous mutation, associated with human congenital heart disease. 140
TranSNPs: A class of functional SNPs affecting mRNA translation potential revealed by fraction-based allelic imbalance 140
Identification of a novel TP53 germline mutation in a large Italian Li-Fraumeni syndrome Family. 139
Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences 139
Compartment-specific and ELAVL1-coordinated regulation of intronic polyadenylation isoforms by doxorubicin 137
PRIMA-1 cytotoxicity correlates with nucleolar localization and degradation of mutant p53 in breast cancer cells. 135
Increased risk of colorectal adenomas in Italian subjects carrying the p53 PIN3 A2-Pro72 haplotype. 135
Noncanonical DNA motifs as transactivation targets by wild type and mutant p53. 134
The kinetics of p53-binding and histone acetylation at target promoters do not strictly correlate with gene expression after UV damage. 134
Functional diversity in the gene network controlled by the master regulator p53 in humans. 134
∆N-P63α and TA-P63α exhibit intrinsic differences in transactivation specificities that depend on distinct features of DNA target sites. 134
Limonium duriusculum (de Girard) Kuntze Exhibits Anti-inflammatory Effect Via NF-kB Pathway Modulation 133
MDM2 SNP309 genotype influences survival of metastatic but not of localized neuroblastoma. 131
XRCC1 deficiency influences the cytotoxicity and the genomic instability induced by Me-lex, a specific inducer of N3-methyladenine. 131
Functional evolution of the p53 regulatory network through its target response elements 129
Functional dissection of sequence-specific NKX2-5 DNA binding domain mutations associated with human heart septation defects using a yeast-based system. 127
PRIMA-1 synergizes with adriamycin to induce cell death in non-small cell lung cancer cells. 124
Tumour p53 mutations exhibit promoter selective dominance over wild type p53 124
The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes. 123
Enhanced cytotoxicity of prenylated chalcone against tumour cells via disruption of the p53-MDM2 interaction 123
Regulation of human PTCH1b expression by different 5' untranslated region cis-regulatory elements 122
Transcriptional functionality of germ line p53 mutants influences cancer phenotype 120
Human dyskerin binds to cytoplasmic H/ACA-box-containing transcripts affecting nuclear hormone receptor dependence 119
Totale 18.575
Salva come PNG Salva come JPEG
Categoria #
all - tutte 80.468
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.327
Totale 81.795
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.012 0 0 0 0 53 40 60 230 108 100 140 281
2022/20231.860 311 247 45 281 164 266 9 116 222 17 106 76
2023/2024663 39 64 43 28 67 205 53 47 7 23 14 73
2024/20252.669 25 18 158 525 170 326 160 206 278 456 169 178
2025/20265.504 388 156 723 682 624 364 1.137 177 449 461 201 142
2026/20272.024 103 281 658 897 85 0 0 0 0 0 0 0
Totale 19.943